Implications of genetic screening

The past decade has witnessed enormous advances in molecular biology that, together with parallel developments in prenatal diagnostic technology, have enabled the introduction of screening programmes for a wide spectrum of genetic disorders. These are discussed in the context of: (1) population carrier testing for cystic fibrosis; (2) pregnancy screening for Down's syndrome, and (3) family screening for ovarian cancer